No extinct species has yet been brought back to life. Not discouraged, Colossal Biosciences adds the Dodo to its list of de-extinction targets

Credit: FunkMonk/Wikimedia Commons (CC BY 2.0)
Credit: FunkMonk/Wikimedia Commons (CC BY 2.0)

Genetic engineering company Colossal Biosciences said [January 31] that it will try to resurrect the extinct dodo bird, and it’s received $150 million in new funding to support its “de-extinction” activities.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Adding the dodo to its official docket brings Colossal’s total de-extinction targets to three: the woolly mammoth (the company’s first target species, announced in September 2021), and the thylacine, a.k.a. the Tasmanian tiger, the largest carnivorous marsupial.

De-extinction is something of a misnomer, as this process, if successful, will yield science’s best analogue for an extinct creature, not the creature itself as it existed in the past. De-extinction methods generally rely on using a living creature’s genetics in the resurrection process. That means any 21st-century mammoth will have at least some modern elephant DNA imbued in it, and any nascent thylacine would be produced from the genome and egg of a related species.

Similarly, it will be difficult to know whether a proxy thylacine, dodo, or mammoth is behaving as a bonafide version of the animal may have behaved. Lots of animal behavior is taught from parents, but a resurrected mammoth would be alone in the world.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_32_36-PM
Viewpoint: The state of U.S. vaccine policy? Dismal nationally, but some states are stepping up.
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claim? The evidence says mostly the opposite
the magic of mRNA
Viewpoint: Anti-vax fake ‘turbo cancer’ claims threaten cancer treatment breakthroughs
ChatGPT-Image-May-7-2026-01_23_27-PM-2
Viewpoint: Will AI democratize personalized cancer treatment or fuel medical misinformation?
artificial intelligence brain think illustration md
Viewpoint — Digital gods and human extinction: Will we be the first species ever to design our own descendants?
Defense_Secretary_Ash_Carter_tours_the_Microsoft_Cybercrime_Center_in_Seattle_March_3_2016
How criminals are using AI to target social media users and steal their money and confidential data
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
ChatGPT Image May 12, 2026, 01_21_30 PM
How big health brands are funding online medical misinformation 
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.